20 April 2010 - Qiagen has today announced the appointment of two high level members, Dr Pia Garguilo and Richard Watts, to the Pharma Business Development team.
The functional group has been established to oversee all new drug-diagnostic co-development programmes with pharma companies.
12 January 2010 - Qiagen has acquired Germany-based ESE, a privately held developer and manufacturer of ultraviolet and fluorescence optical measurement devices. 17 September 2009 - Qiagen has acquired additional licences from Roche and Idaho Technology related to the use of instrumentation and reagents for PCR-based molecular testing.
